NBY / NovaBay Pharmaceuticals, Inc. - Institutionelt ejerskab - Købere

NovaBay Pharmaceuticals, Inc.
US ˙ NYSEAM

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i NovaBay Pharmaceuticals, Inc., omfatter Rangeley Capital, LLC, og StoneX Group Inc. .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-12 13F XTX Topco Ltd 20.310 2,33 12 0,00
2025-08-14 13F Two Sigma Securities, Llc 24.280 38,96 14 40,00
2025-07-17 13F C2C Wealth Management, LLC 98.000 78,18 57 75,00
2025-08-14 13F UBS Group AG 3.385 351,94 2
2025-08-12 13F Proequities, Inc. 0 0
2025-08-14 13F Bank Of America Corp /de/ 55 27,91 0
2025-07-24 NP FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 27.647 10,41 15 0,00
2025-08-14 13F Rangeley Capital, LLC 33.210 19
2025-08-13 13F/A StoneX Group Inc. 14.877 4
Other Listings
DE:B9P0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista